Maryland House Bill HB1481

Maryland 2026 Regular Session

• Introduced: 2/13/26
• Refer: 2/13/26

Caption

Tissue Banks and Hospitals - Autologous and Directed Blood Donations

Impact

If enacted, this legislation will amend existing health laws in Maryland by adding specific regulations regarding how hospitals and tissue banks manage blood donation programs. Healthcare providers will be required to comply with patient requests for autologous and directed donations unless certain logistical or regulatory constraints arise. This shift is anticipated to improve patient care by enabling more personalized treatment options and ensuring that patients are informed about their donation options in line with informed consent standards.

Summary

House Bill 1481 addresses the protocols surrounding autologous and directed blood donations in the context of hospitals and tissue banks. It explicitly prohibits these institutions from denying patients the right to request physician-ordered blood donations under specific conditions. The bill aims to provide clear pathways for patients to utilize their own blood or that of designated individuals during medical procedures, thereby enhancing patient autonomy in requesting blood transfusions appropriate for their medical needs.

Contention

Notably, there may be points of contention regarding the practical implications of this bill. Opponents may argue that mandating hospitals to allow these donations could lead to complications in emergency situations or not align with current safety and regulatory standards governing blood donations. Furthermore, the balance between patient autonomy and hospital policies could be a topic of debate, particularly regarding how hospitals will adjust their internal protocols without compromising patient safety or care quality.